Author： Boyer Laurent Auquier Pascal
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.30, Iss.6, 2012-06, pp. : 531-532
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Individualised medicine creates a shared responsibility?
Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. :
Access to resources
Recommend
A Review of Health-Related Quality-of-Life Measures in Stroke
By Golomb B.A.
PharmacoEconomics, Vol. 19, Iss. 2, 2001-01 ,pp. :
Valuing Children's Health: Whose Quality of Life Matters?
PharmacoEconomics, Vol. 30, Iss. 8, 2012-08 ,pp. :
Impact of Atypical Antipsychotics on Quality of Life in Patients with Schizophrenia
CNS Drugs, Vol. 18, Iss. 13, 2004-01 ,pp. :
Best options for schizophrenia in Slovenia?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 545, 2008-01 ,pp. :